IL15 and lymphoma: NIZ985 is a recombinant heterodimer of IL-15 and the IL-15 receptor alpha, mimicking the transpresentation of IL-15, which induces significant proliferation and IFNγ production in NK cells from patients with metastatic or unresectable solid tumours and is currently under evaluation in phase I/Ib trial in patients with advanced solid tumours or lymphoma (NCT04261439).